Arkolith/Insider Trading/BRTX/Form 4

Alstodt Lance

President, CEO, COB, Director, 10% OwnerBioRestorative Therapies, Inc. (BRTX) · full profile →Form 4 · filed Oct 20, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 6, 2025Grant(A)16K$1.60$25K187K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 6, 2025Grant(A)12K—$012K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001021771-25-000140) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML